The mission of the Mucociliary Clearance and Aerosol Research Laboratory is to use inhaled aerosols:
- As a tool for studying lung physiology and
- To improve treatment of pulmonary diseases such as cystic fibrosis, asthma, and chronic obstructive lung disease.
Our extensive knowledge and experience in the use of radiolabeled aerosols and gamma scintigraphy allows us to assess clearance of mucus from the airways and the delivery of aerosols to the lung. We provide state-of-the-art clinical, animal, and bench research services for evaluating:
- The effectiveness of new therapies for improving clearance of secretions from the lung and
- The efficiency of drug delivery to the lungs for new aerosol treatment devices.